Clinical Trials
11 trialsNCT00588770 2026-05-26
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00003592 2023-06-22
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT01156142 2017-08-09
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00041171 2016-07-12
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn
NCT02048254 2016-06-13
Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer
Peking University
Phase 3 Unknown
NCT00022373 2014-10-15
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed
NCT00021125 2013-06-26
Radiation Therapy in Treating Patients With Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00090337 2013-03-07
Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT00017511 2012-05-16
Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Daiichi Sankyo
Phase 3 Completed
NCT01216800 2010-10-07
Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors
National Cancer Institute (NCI)
Phase 3 Unknown